Novel Concepts Medical announces breakthrough in COVID-19 research

The startup company Novel Concepts Medical has announced major breakthrough in its research of COVID-19.

Its novel plant-based treatment has resulted in successfully inhibiting the COVID-19 Omicron variant and blocking its connection to human cells, the company said in its press release.

According to the company, earlier testing demonstrated:
Stopping the COVID-19 virus’s entry to the cells and stopping its progress
In case studies, volunteers had negative PCR results within 48 hours and quickly recovered from more than 16 symptoms of long COVID-19, including memory loss, loss of taste and smell, headaches, fatigue, and many symptoms that are common to both COVID-19 and the flu.

“Our cure can STOP Omicron, the COVID-19 virus, and Long COVID-19 symptoms. We can help reduce the high numbers of people catching COVID-19 every week. We can also help provide emergency assistance to those countries that have low vaccination rates. Our plant-based cure is safe and without any known side effects,” said founder and inventor, Dr. Rachel Alkalay.

Dr. Alkalay added that due to the fact that all its compounds are approved for other uses, she believes the road to get emergency use authorization will be faster. The company, which has a vast array of life-saving medicines, including a dementia and memory-loss cure that was successfully tested on many Long COVID-19 volunteers, is planning to hold an initial public offering in 2022.